4.7 Review

Role of IncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes

期刊

DRUG DISCOVERY TODAY
卷 23, 期 9, 页码 1635-1643

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2018.04.010

关键词

-

资金

  1. National Institutes of Health Grant [R01CA204552, R01CA210192, R01CA206069]
  2. UTHSC-College of Pharmacy-Dean's Seed Grant
  3. UTHSC New Grant Mechanism Award
  4. UTHSC-CORNET
  5. UTHSC-Clinical CORNET award
  6. [K22CA174841]
  7. [CA213232]

向作者/读者索取更多资源

Long noncoding RNAs (lncRNAs) are a class of noncoding RNA, involved in regulation of diverse physiological and pathological processes. Ovarian cancer is the leading cause of death among all gynecological malignancies in the world and its underlying mechanism is still unclear. LncRNAs exhibit multiple biological functions in various stages of ovarian cancer development. We will discuss and summarize the new and important lncRNAs and their involvement in disease, which might represent promising therapeutic targets. Therapeutic intervention based on silencing or functional inhibition of target lncRNAs will be beneficial for ovarian cancer patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据